Bluewind Medical Answers FCC Questions on Waiver Request
Bluewind Medical executives answered technical questions on the company’s request for a waiver to permit its implantable medical device system operating at 6.78 MHz to exceed FCC emission limits (see 2301190018), in meetings with FCC Office of Engineering and Technology…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
staff. Bluewind “answered the Commission’s questions regarding the operation of the device, including the process for confirming the positioning of the device on a patient, the timeframes for treatment, the power levels during each phase of operation and potential conditions associated with certification of the device,” said a filing Tuesday in docket 23-27.